🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Roche Holding
-4.58%
Pharma / Pharma
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | Web1. Regulatory Risk: Roche Holding AG operates in a heavily regulated industry and must comply with stringent regulations in each of the countries where it operates. Regulatory changes or stringent implementation could significantly affect its business operations.
2. Competition Risk: Roche Holding AG operates in an industry with many competitors and may face increasing competition from other large pharmaceutical companies.
3. Adverse Market Conditions: Roche Holding AG operates in a cyclical industry and therefore, its operations and financial performance can be significantly impacted by adverse market conditions.
4. Intellectual Property Risks: As a research-oriented company, Roche Holding AG’s success depends heavily upon its innovative products, which it must protect with patents and other legal rights. These rights can be vulnerable to risk of infringement by competitors or other parties.
5. Currency Risk: Currency risk is inherent in a global company like Roche Holding AG as its revenues and profits are affected by changes and fluctuations in exchange rates.
Wait! There's more — sign up for free or log in